logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Essential Hypertension

    FiltersReset Filters
    22 results

    • amlodipine and valsartan

      (amlodipine and valsartan)
      Macleods Pharmaceuticals Limited
      Usage: Amlodipine and valsartan tablets are indicated for the treatment of hypertension to lower blood pressure, reducing the risk of cardiovascular events such as strokes and heart attacks. They may be used for patients not controlled on monotherapy and as initial therapy in those likely to require multiple drugs.

    • benicar

      (olmesartan medoxomil)
      Cosette Pharmaceuticals, Inc.
      Usage: Benicar is indicated for treating hypertension in adults and children aged six and older to lower blood pressure, reducing the risk of cardiovascular events like strokes and heart attacks. It can be used alone or with other antihypertensive medications as part of comprehensive cardiovascular risk management.

    • benicar hct

      (olmesartan medoxomil-hydrochlorothiazide)
      Cosette Pharmaceuticals, Inc.
      Usage: BENICAR HCT (olmesartan medoxomil and hydrochlorothiazide) is indicated for the treatment of hypertension to lower blood pressure. It is not intended for initial therapy and may be used alone or with other antihypertensive medications to reduce cardiovascular risk, including strokes and myocardial infarctions.

    • bystolic

      (nebivolol hydrochloride)
      Allergan, Inc.
      Usage: BYSTOLIC is indicated for the treatment of hypertension to lower blood pressure, which reduces the risk of cardiovascular events such as strokes and myocardial infarctions. It can be used alone or in combination with other antihypertensive agents as part of comprehensive cardiovascular risk management.

    • caduet

      (amlodipine besylate and atorvastatin calcium)
      Pfizer Laboratories Div Pfizer Inc
      Usage: CADUET (amlodipine and atorvastatin) is indicated for patients requiring both hypertension management and lipid control. Amlodipine treats high blood pressure and various types of angina, while atorvastatin reduces risk of cardiovascular events and lowers LDL cholesterol in hyperlipidemia.

    • captopril

      (Captopril)
      Ajanta Pharma USA Inc.
      Usage: Captopril tablets are indicated for treating hypertension, congestive heart failure, left ventricular dysfunction post-myocardial infarction, and diabetic nephropathy in patients with type I diabetes. They may be used alone or with other antihypertensives and are particularly beneficial for patients with renal impairment or specific complications.

    • carospir

      (CaroSpir)
      CMP Pharma, Inc.
      Usage: CAROSPIR is indicated for the treatment of NYHA Class III-IV heart failure with reduced ejection fraction, hypertension as an add-on therapy, and edema in adult cirrhotic patients unresponsive to fluid and sodium restriction. It aims to improve survival, manage edema, and reduce hospitalization for heart failure.

    • carvedilol

      (Carvedilol)
      Zydus Pharmaceuticals USA Inc.
      Usage: Carvedilol is indicated for treating mild-to-severe chronic heart failure, reducing cardiovascular mortality in stable post-myocardial infarction patients with left ventricular dysfunction, and managing essential hypertension, either alone or in combination with other antihypertensive agents.

    • cleviprex

      (clevipidine)
      Chiesi USA, Inc.
      Usage: Cleviprex is indicated for lowering blood pressure in situations where oral medication is not feasible or desirable.

    • diltiazem hydrochloride extended-release

      (Diltiazem Hydrochloride)
      Mayne Pharma
      Usage: Diltiazem Hydrochloride Extended-Release Capsules are indicated for treating hypertension, either alone or in combination with other antihypertensive agents like diuretics.